Abstract
BackgroundAntibody–drug conjugates (ADCs) that deliver cytotoxic drugs to tumor cells have emerged as an effective and safe anticancer therapy. ADCs may induce immunogenic cell death (ICD) to promote additional endogenous...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have